Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 10/20 | 0.96 |
| ▸ | PPARG | P37231 | 8/20 | 0.96 |
| ▸ | F7 | P08709 | 7/20 | 0.96 |
| ▸ | F3 | P13726 | 7/20 | 0.96 |
| ▸ | CYP19A1 | P11511 | 6/20 | 0.96 |
| ▸ | PPARD | Q03181 | 6/20 | 0.96 |
| ▸ | PPARA | Q07869 | 6/20 | 0.96 |
| ▸ | PTGS1 | P23219 | 5/20 | 0.96 |
| ▸ | FFAR1 | O14842 | 5/20 | 0.96 |
| ▸ | MAPT | P10636 | 4/20 | 0.96 |
| ▸ | OXER1 | Q8TDS5 | 4/20 | 0.96 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.96 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.96 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.96 |
| ▸ | LMNA | P02545 | 3/20 | 0.96 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.96 |
| ▸ | HPGD | P15428 | 3/20 | 0.96 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.96 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.96 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.96 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7755128 | 1.00 | ALDH1A1 (0.96) | ALDH1A1PPARGF7F3CYP19A1 | |
| SCHEMBL14695123 | 1.00 | ALDH1A1 (0.96) | ALDH1A1PPARGF7F3CYP19A1 | |
| SCHEMBL15994739 | 1.00 | ALDH1A1 (0.96) | ALDH1A1PPARGF7F3CYP19A1 | |
| SCHEMBL606015 | 1.00 | ALDH1A1 (0.96) | ALDH1A1PPARGF7F3CYP19A1 | |
| SCHEMBL606358 | 1.00 | ALDH1A1 (0.96) | ALDH1A1PPARGF7F3CYP19A1 | |
| SCHEMBL4452323 | 1.00 | ALDH1A1 (0.96) | ALDH1A1PPARGF7F3CYP19A1 | |
| SCHEMBL29226 | 1.00 | ALDH1A1 (0.96) | ALDH1A1PPARGF7F3CYP19A1 | |
| SCHEMBL10444557 | 1.00 | ALDH1A1 (0.96) | ALDH1A1PPARGF7F3CYP19A1 | |
| SCHEMBL2574641 | 1.00 | ALDH1A1 (0.96) | ALDH1A1PPARGF7F3CYP19A1 | |
| SCHEMBL14161584 | 1.00 | ALDH1A1 (0.96) | ALDH1A1PPARGF7F3CYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 958 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4496474-A1 | AGRICULTURAL COMPOSITION | Oro Agri Europe S.A. (PT) | 2025-01-29 | — | — | EP | claimed |
| EP-4294375-A1 | METHODS OF LOADING EXTRACELLULAR VESICLES | Lonza Sales AG (CH) | 2023-12-27 | — | — | EP | claimed |
| EP-4259280-A1 | COMPOSITIONS AND METHODS FOR PREVENTING, ATTENUATING, AND TREATING MEDICAL CONDITIONS WITH SHDL NANOPARTICLES | The Regents Of The University Of Michigan (US) | 2023-10-18 | — | — | EP | claimed |
| WO-2023180932-A1 | AGRICULTURAL COMPOSITION | ORO AGRI EUROPE, S.A. (PT) | 2023-09-28 | — | — | WO | claimed |
| EP-4232060-A1 | COMPOSITIONS AND METHODS FOR TREATING CARDIOVASCULAR RELATED DISORDERS | The Regents Of The University Of Michigan (US) | 2023-08-30 | — | — | EP | claimed |
| US-20220354963-A1 | EXTRACELLULAR VESICLE LINKED TO MOLECULES AND USES THEREOF | CODIAK BIOSCIENCES, INC. (US) | 2022-11-10 | — | — | US | claimed |
| WO-2022178147-A1 | METHODS OF LOADING EXTRACELLULAR VESICLES | CODIAK BIOSCIENCES, INC. (US) | 2022-08-25 | — | — | WO | claimed |
| WO-2022125878-A1 | COMPOSITIONS AND METHODS FOR PREVENTING, ATTENUATING, AND TREATING MEDICAL CONDITIONS WITH SHDL NANOPARTICLES | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2022-06-16 | — | — | WO | claimed |
| WO-2022087058-A1 | COMPOSITIONS AND METHODS FOR TREATING CARDIOVASCULAR RELATED DISORDERS | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2022-04-28 | — | — | WO | claimed |
| CN-112996500-A | Compositions and methods for modulating ELOVL2 | 优美佳生物技术有限公司 | 2021-06-18 | — | — | CN | claimed |
| EP-0782827-B1 | USE OF A BALANCING AGENT FOR OMEGA-6 AND OMEGA-3 UNSATURATED FATTY ACIDS | SUNTORY LTD (JP) | 2003-10-01 | — | — | EP | claimed |
| US-20030144353-A1 | Functional acylglycerides | NATURAL ASA (NO) | 2003-07-31 | — | — | US | claimed |
| WO-2003043972-A2 | FUNCTIONAL ACYLGLYCERIDES | NATURAL AS (NO) | 2003-05-30 | — | — | WO | claimed |
| WO-2003035051-A2 | THE USE OF PROTON SEQUESTERING AGENTS IN DRUG FORMULATIONS | INHALE THERAPEUTIC SYSTEMS, INC. (US) | 2003-05-01 | — | — | WO | claimed |
| EP-0965578-B1 | Novel triglyceride and composition comprising the same | SUNTORY LTD (JP) | 2003-04-16 | — | — | EP | claimed |
| WO-2003005628-A2 | GENERATING, VIEWING, INTERPRETING, AND UTILIZING A QUANTITATIVE DATABASE OF METABOLITES | LIPOMICS TECHNOLOGIES, INC. (US) | 2003-01-16 | — | — | WO | claimed |
| US-6248909-B1 | STRUCTURE OF THE HUMAN BREAST MILK TYPE, WHICH TRIGLYCERIDE HAS A SATURATED FATTY ACID HAVING 16-18 CARBON ATOMS AT THE POSITION 2, AND UNSATURATED ACYL AT THE POSITION 1 AND/OR 3 | SUNTORY LIMITED (JP) | 2001-06-19 | — | — | US | claimed |
| EP-0965578-A1 | Novel triglyceride and composition comprising the same | SUNTORY LIMITED (JP) | 1999-12-22 | — | — | EP | claimed |
| US-5948451-A | Method of modifying the balance of omega unsaturated fatty acids using a dioxabicyclo octane derivative | SUNTORY LIMITED (JP) | 1999-09-07 | — | — | US | claimed |
| EP-0782827-A1 | FOOD COMPOSITION CONTAINING BALANCING AGENT FOR $g(v)-6 AND $g(v)-3 UNSATURATED FATTY ACIDS | SUNTORY LIMITED (JP) | 1997-07-09 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030144353-A1 | Functional acylglycerides | ELOVL3, CPT1B, ELOVL6 | ALDH1A1 1714/4885PPARG 67/4885F7 4122/4885 |
| US-20220354963-A1 | EXTRACELLULAR VESICLE LINKED TO MOLECULES AND USES THEREOF | EXOSC5, EXOSC4, EXOSC10 | ALDH1A1 2475/4885PPARG 4131/4885F7 4406/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.